Emami Ltd

Pursuant to Provision of Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we are enclosing herewith copy of Presentation on Company’s Performance update for the quarter ended 30th June, 2022.
The aforesaid information is also disclosed on the website of the company
www.emamiltd.in . This is for your information and records.
Thanking you,
Yours faithfully,
For Emami Limited
— A. K. Joshi
Company Secretary & VP- Legal
(Encl. : As above)
regd. office: 687 anandapur e. m. bypass kolkata 700107 india
phone: 91 33 6613 6264 telefax: 91 33 6613 6600 e-mail: [email protected]:www.emamiltd.in
Q1FY23 Performance Update
29th July 2022
2
Revenue Growth
Q1FY23
Growth (%)
Over PY Last year
Growth
• Domestic Business 13%* 42%
• International Business 45% 17%
Consolidated Net Sales 17% 38%
• Other Operating Income 54% -21%
Total Revenues 18% 37%
Dermicool contributed to 8% of Domestic Net Sales in Q1FY23 Flattish volume growth in Domestic sales excluding Dermicool Sales Contribution Domestic 85% International 15% Total Volume growth of 9.6% Volume growth of 2.4% excluding Dermicool 3 Broadbased growth across portfolio despite corrections in Pain Management & Healthcare Range… -25% Healthcare Range 59% growth in base quarter -30% Pain Management 70% growth in base quarter 4 Modern Channels continue to perform well Growth & salience to Domestic sales excluding Dermicool Q1FY23 Growth 55% Q1FY23 Salience 7.6% (+260 bps) E-Commerce Q1FY23 Growth 42% Q1FY23 Salience 8.2% (+230 bps) Modern Trade 5 Brand/ Business Performance analysis Domestic brand wise & International sales performance analysis in Q1 FY23 6 Navratna ▹ Sales grew by 29% ▹ Launched ₹ 20 bridge packs for Navratna Oil (27 ml) and Navratna Cool Talc (30 gm) ▹ Tapped into new age consumers through digital marketing initiatives like – ▸ Short Video format activities ▸ Contextual advertisements across platforms ▸ Brand integration in both national and regional content 7 Pain Management ▹ Sales declined by 30% on a high base of 70% growth in previous year ▸ 3 year CAGR of 10%; ▹ Driving prominence and visibility at chemist outlets in key markets ▸ Improvised brand assortment and conversion through dedicated chemist led visibility inputs. ▹ Direct consumer connect for Zandu Ortho Vedic Oil by samplings in fairs and festivals 8 Kesh King ▹ Sales grew by 20% ▹ Launched 30 ml bridge pack at ₹ 49/- for Kesh King Oil to increase penetration ▹ Kesh King shampoo sachet driven with focused distribution drives, and large scale sampling. ▸ Sachet contribution to shampoo sales increased to 10% in Q1FY23 compared to 4% in Q1FY22 ▹ Conducted on ground activations to improve brand visibility & recall 9 Male Grooming ▹ Sales grew by 32% ▹ Launched Fair and Handsome Cream 30gm shelf ready pack of 6 pcs to drive key functional benefits (7 hr. Brighter Look) at point of sale. ▹ Modern Trade Visibility, Consumer offer, Digital Communication and Chemist Channel activation programmes conducted for Fair and Handsome Facewash 10 BoroPlus ▹ Sales growth flat over previous year; 3 year CAGR of 6% ▹ New launches – BoroPlus Aloe Vera Gel and BoroPlus Soap performing well ▹ Launched new variant of BoroPlus Aloe Vera Gel: 100% Organic BoroPlus Aloe Vera Gel with Green Tea ▸ Listed on major Ecommerce & MT platforms 11 Healthcare Range ▹ Sales declined by 25% on a high base of 59% growth in previous year ▸ 3 year CAGR of 13%; ▸ Immunity portfolio declined significantly due to higher sales in base quarter due to the 2nd wave of the pandemic; ▹ Launched Zandu Stevia (Meethi Tulsi), Zandu Bone Care Juice and Zandu Vitality Booster juice on Zanducare 12 Dermicool ▹ Sales commenced from Apr’22 ▹ Contributed to 8% of Domestic sales in Q1FY23 ▹ Marketing initiatives in pipeline- ▸ Imagery revamp with superior brand repositioning ▸ Industry benchmark claims on pack & communication supported with marketing investment to connect with new consumers ▸ Launch new pack sizes to drive trials & increase penetration ▸ Geography and channel expansion drives 13 International Business ▹ Sales grew by 45% ▹ Growth led by MENA & SAARC ▹ All major brands – 7 Oils in One, Navratna, Fair and Handsome, Kesh King and BoroPlus performed well SAARC 33% MENA 45% CIS 9% AFRICA & OTHERS 13% Q1FY23 International Business Region wise sales salience SAARC South Asian Association for Regional Cooperation (Major countries – Bangladesh, Nepal, Sri Lanka etc.) MENA Middle East & North Africa (Major countries – KSA, UAE, Qatar, Oman, Kuwait, Bahrain etc.) CIS Commonwealth of Independent States (Major Countries – Russia, Ukraine etc.) 14 Financial Performance analysis Earnings analysis for Q4 & FY22 15 Q1FY23 Profitability (Consolidated) Q1FY23 ₹ in crore Growth over Q1FY22 Last year Growth Q1FY23 Margins Margin Growth over PY Revenues 778 18% 37% – – Gross Profit 487 12% 36% 62.6% -340 bps EBIDTA 173 2% 38% 22.3% -340 bps Reported PAT 74 -5% 96% 9.5% -230 bps Adjusted PAT 138 0% 45% 17.7% -310 bps
*Adjusted PAT = Reported PAT + Exceptional Items + Amortization of Kesh King & other brand related intangible assets
16
Q1FY23 Financial Analysis
Cost of Goods Sold
(as a % of sales)
34.0%
37.4%
Q1FY22 Q1FY23
+340 bps
Staff Costs
(as a % of sales)
12.8% 11.4%
Q1FY22 Q1FY23
-140 bps
A&P Costs
(as a % of sales)
16.6% 17.5%
Q1FY22 Q1FY23
+90 bps
Admin & Other Exp
(as a % of sales)
+50 bps
10.9% 11.4%
Q1FY22 Q1FY23
Other Income
(₹ in Millions)
107
63
Q1FY22 Q1FY23
Interest Paid
(₹ in Millions)
6
25
Q1FY22 Q1FY23
17
Q1FY23 Consolidated Financials
*Adjusted PAT = Reported PAT + Exceptional Items + Amortiz